Immunotherapy for polyomaviruses: opportunities and challenges (Q38025665)

27 August 2017

Immunotherapy for polyomaviruses: opportunities and challenges (English)

1 reference

27 August 2017

1 reference

Tina Dalianis

1

1 reference

27 August 2017

1 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

4

1 reference

27 August 2017

6

1 reference

27 August 2017

617-628

1 reference

A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice

27 August 2017

1 reference

Studies on polyomavirus persistence and polyomavirus-induced tumor development in relation to the immune system

21 January 2018

1 reference

The vacuolating virus, S.V. 40

21 January 2018

1 reference

Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association

21 January 2018

1 reference

New human papovavirus (B.K.) isolated from urine after renal transplantation

21 January 2018

1 reference

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

21 January 2018

1 reference

BK virus and human cancer: innocent until proven guilty

21 January 2018

1 reference

JC virus: an oncogenic virus in animals and humans?

21 January 2018

1 reference

JC virus infection of the brain

21 January 2018

1 reference

Identification of a third human polyomavirus

21 January 2018

1 reference

Identification of a novel polyomavirus from patients with acute respiratory tract infections

21 January 2018

1 reference

Clonal integration of a polyomavirus in human Merkel cell carcinoma

21 January 2018

1 reference

Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin

21 January 2018

1 reference

Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient

21 January 2018

1 reference

A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus

21 January 2018

1 reference

Seroepidemiology of human polyomaviruses

21 January 2018

1 reference

Seroprevalence of human polyomavirus 9 and cross-reactivity to African green monkey-derived lymphotropic polyomavirus

21 January 2018

1 reference

Taxonomical developments in the family Polyomaviridae

21 January 2018

1 reference

Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.

21 January 2018

1 reference

Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs.

21 January 2018

1 reference

Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus

21 January 2018

1 reference

Gene regulation by sense-antisense overlap of polyadenylation signals.

21 January 2018

1 reference

Clinical polyomavirus BK variants with agnogene deletion are non-functional but rescued by trans-complementation

21 January 2018

1 reference

Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate

21 January 2018

1 reference

The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry

21 January 2018

1 reference

Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer.

21 January 2018

1 reference

Human papillomavirus vaccines: current status and future prospects

21 January 2018

1 reference

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

21 January 2018

1 reference

Serological cross reactivity between polyomavirus capsids

21 January 2018

1 reference

A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors

21 January 2018

1 reference

Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus

21 January 2018

1 reference

SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy.

21 January 2018

1 reference

VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.

21 January 2018

1 reference

Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies

21 January 2018

1 reference

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

21 January 2018

1 reference

BK virus (BKV) quantification in urine samples of bone marrow transplanted patients is helpful for diagnosis of hemorrhagic cystitis, although wide individual variations exist.

21 January 2018

1 reference

Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation

21 January 2018

1 reference

BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients

21 January 2018

1 reference

Overrepresentation of point mutations in the Sp1 site of the non-coding control region of BK virus in bone marrow transplanted patients with haemorrhagic cystitis

21 January 2018

1 reference

Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study

21 January 2018

1 reference

Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation

21 January 2018

1 reference

BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results

21 January 2018

1 reference

Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy.

21 January 2018

1 reference

Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy and natalizumab

21 January 2018

1 reference

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

21 January 2018

1 reference

Merkel cell carcinoma: a clinicopathologic study with prognostic implications.

21 January 2018

1 reference

Quantitation of human seroresponsiveness to Merkel cell polyomavirus

21 January 2018

1 reference

Trichodysplasia spinulosa is characterized by active polyomavirus infection

21 January 2018

1 reference

Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour development

21 January 2018

1 reference

Polyoma tumor development in neonatally polyoma-virus-infected CD4-/- and CD8-/- single knockout and CD4-/-8-/- double knockout mice

21 January 2018

1 reference

Human polyomavirus DNA is not detected in Guthrie cards (dried blood spots) from children who developed acute lymphoblastic leukemia.

21 January 2018

1 reference

Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens

21 January 2018

1 reference

T cell subsets involved in immunity against polyoma virus-induced tumors

21 January 2018

1 reference

Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen

21 January 2018

1 reference

Immunity to polyomavirus infection: the polyomavirus-mouse model

21 January 2018

1 reference

Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

21 January 2018

1 reference

Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.

21 January 2018

1 reference

Immunotherapeutic polyoma and human papilloma virus-like particles

21 January 2018

1 reference

Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor

21 January 2018

1 reference

Murine pneumotropic virus chimeric Her2/neu virus-like particles as prophylactic and therapeutic vaccines against Her2/neu expressing tumors

21 January 2018

1 reference

CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particles

21 January 2018

1 reference

Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor

21 January 2018

1 reference

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

21 January 2018

1 reference

Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine

21 January 2018

1 reference

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).

21 January 2018

1 reference

Human papillomavirus-specific immune therapy: failure and hope

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.12.51

1 reference

27 August 2017

1 reference

PubMed ID

22788129